Previous Topic

Next Topic

Book Contents

Book Index

Overview

The Medicines and Healthcare products Regulatory Agency (MHRA) collects reports of suspected adverse drug reactions (ADRs) via the Yellow Card Scheme. These provide a source of information on potential drug safety issues allowing the Agency to take regulatory action to protect public health. Currently, healthcare professionals report suspected ADRs by either completing a paper or web based form. Electronic Yellow Card reporting is now integrated in Vision and allows you to:

When a report is created, it is automatically populated with the information on the Allergy and Intolerance form along with relevant patient and practice information where available.

Once complete, the Yellow Card information is saved on the patient record and a report is sent via the Vision Message Bus to the MHRA website.

Please see the Medicines and Healthcare products Regulatory Agency (MHRA) Website for further background information on the Yellow Card Scheme.